The introduction of PID patients in the PV surveillance strategies, in addition to AFP cases, is now seriously considered as a supplemental strategy to enhance the sensitivity of PV detection, particularly in these advanced phases of the global polio eradication program, and our results support the usefulness of such strategies. This evidence concerns the gene AFP and acquired polycythemia vera.